biochemical research scientist team working with microscope for coronavirus vaccine development in pharmaceutical research labolatory biochemical research scientist team working with microscope for coronavirus vaccine development in pharmaceutical research labolatory | © Mongkolchon Akesin - gettyimages.com

Event Switzerland Structural Change

Investor Seminar: Mecklenburg-Vorpommern

A Dynamic MedTech and Life Sciences Hub in Northern Germany

As part of the Internationalization of Regions in Structural Transformation (ISW) program, Germany Trade & Invest, in cooperation with Invest in MV  (Economic Development Agency of Mecklenburg-Vorpommern) is hosting an investor event for Swiss Companies and Institutions about market opportunities in Northeastern Germany with focus on Medical Technologies.

10 Jun 2026

Event Bern, Switzerland Structural Change
Investor Seminar: Mecklenburg-Vorpommern - A Dynamic MedTech and Life Sciences Hub in Northern Germany

Register here

This investor event provides insights into current investment and cooperation opportunities in Mecklenburg-Vorpommern, a dynamic region in northern Germany with strong expertise in medical technology and life sciences.

Participants will have the opportunity to engage directly with experts from Germany Trade & Invest and Invest in MV, as well as industry specialists and Swiss companies already active in the region.

The event will conclude with an apéro riche and networking session, offering space for personal exchange with experts and decision-makers.

Look forward to individual exchange with our experts and take your first business steps into Germany!

Registration & Information 
Are you interested? Visit the event website to view detailed information about the program of events and participating speakers and register directly for the event. We look forward to your active participation!

  Key Topics

  • Investment opportunities in Mecklenburg-Vorpommern in the fields of life sciences and medtech
  • Overview of the German medical technology market
  • Panel discussion on opportunities, success stories, and perspectives for Swiss companies
  • Networking with experts and decision-makers

Target Audience

The event is aimed at:

  • Growth- and innovation-oriented companies in life sciences, pharmaceuticals, and medical technology
  • Investors, project developers, and strategic partners interested in cooperation, investment, or business expansion projects

Speakers

  • Gabriel Flemming, Deputy Director Chemicals & Healthcare, Germany Trade & Invest
  • Ulrich Paustian, Project Manager, Invest in MV
  • Dr. Carsten Mahrenholz, Founder & CEO, Coldplasmatech GmbH
  • Dr. Dirk Forberger, CEO, RoweMed AG – Medical 4 Life
  • Daniela Lau, Project Manager Business Development, Southwest Mecklenburg

Programme

  • From 5:00 PM – Arrival of participants
  • 5:30 – 5:45 PM – Welcome and opening
  • 5:45 – 6:00 PM – Keynote: Overview of the German medical technology landscape
  • 6:00 – 6:35 PM – Panel discussion:
    MedTech and Life Sciences in Mecklenburg-Vorpommern – Opportunities, success stories, and perspectives for Swiss companies
  • 6:35 PM – Q&A
  • 6:40 PM – Key takeaways
  • 6:45 PM – Apéro riche and networking

 

Contact & Organisation

German-Swiss Chamber of Commerce
Tödistrasse 60, 8002 Zurich

Contact person: Verena Miller
Phone: +41 44 283 61 70
Email: verena.miller@handelskammer-d-ch.ch

 

GTAI Investor Event

The investor event provides insights into the current developments of a focus industry in Germany and outlines options on how best to expand your business activities to Europe's largest market. Benefit from exclusive information on areas that offer particularly attractive points of contact and get to know the ecosystem of a specific region. Companies that have already successfully established themselves in the region will also report on their experiences in the German market.